LMNL logo

Liminal BioSciences (LMNL) Operating Profit

Annual Operating Profit

-$25.18 M
+$14.40 M+36.39%

December 31, 2022

Summary

Performance

1-Year Change

+36.39%

3-Year Change

+36.69%

5-Year Change

+68.76%

15-Year Change

+68.76%

LMNL Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.72 M
LMNL annual operating income is currently -1564.52% below its historical high of $1.72 million

3-Year Low

-$39.59 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
LMNL previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
LMNL next annual earnings announcement has not yet been scheduled

OtherLMNLprofitabilitymetrics:

Annual Operating Margin

-8170.33%
LMNL annual operating profit margin is -8170.33%

Annual Revenue

$308.20 K
LMNL annual revenue is $308.20 thousand

Annual Net Income

$384.30 K
LMNL annual net profit is $384.30 thousand

Annual EPS

$0.12
LMNL annual earnings per share is $0.12

Quarterly Operating Profit

-$6.69 M
-$1.08 M-19.28%

June 30, 2023

Summary

Performance

3-Month Change

-19.28%

1-Year Change

-1.43%

3-Year Change

+25.47%

5-Year Change

+68.25%

LMNL Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$29.13 M
LMNL quarterly operating income is currently -122.97% below its historical high of $29.13 million

3-Year Low

-$8.03 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
LMNL previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
LMNL next earnings announcement has not yet been scheduled

OtherLMNLprofitabilitymetrics:

Quarterly Operating Margin

-8038.42%
LMNL quarterly operating profit margin is -8038.42%

Quarterly Revenue

$83.30 K
LMNL quarterly revenue is $83.30 thousand

Quarterly Net Income

-$6.80 M
LMNL quarterly net profit is -$6.80 million

Quarterly EPS

-$2.19
LMNL quarterly earnings per share is -$2.19

TTM Operating Profit

-$23.63 M
-$94.20 K-0.40%

June 30, 2023

Summary

Performance

3-Month Change

-0.4%

1-Year Change

+28.58%

3-Year Change

-13.59%

5-Year Change

+40.08%

LMNL TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.01 M
LMNL TTM operating income is currently -688.57% below its historical high of $4.01 million

3-Year Low

-$39.59 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
LMNL previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
LMNL next earnings announcement has not yet been scheduled

OtherLMNLprofitabilitymetrics:

Annual Operating Margin

-8170.33%
LMNL annual operating profit margin is -8170.33%

TTM Revenue

$363.50 K
LMNL TTM revenue is $363.50 thousand

TTM Net Income

$903.00 K
LMNL TTM net profit is $903.00 thousand

TTM EPS

$0.27
LMNL TTM earnings per share is $0.27

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$25.18 M
LMNL annual operating income is -$25.18 million

Annual Gross Profit

-
LMNL annual gross profit value is unknown

Annual Operating Expenses

$25.49 M
LMNL annual total operating expenses is $25.49 million

LMNL Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+36.4%-1.4%+28.6%
3 y3 years+36.7%+25.5%-13.6%
5 y5 years+68.8%+68.3%+40.1%

LMNL Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+57.2%+27.0%+20.0%+0.4%+67.6%
5 y5-yearat high+57.9%-123.0%+199.1%+201.5%+89.5%
alltimeall time-1564.5%+253.6%-123.0%+348.4%-688.6%+304.4%

Liminal BioSciences Operating Profit History

DateAnnualQuarterlyTTM
Jun 2023
-
-$6.69 M(+19.3%)
-$23.63 M(+0.4%)
Mar 2023
-
-$5.61 M(+6.4%)
-$23.53 M(-6.2%)
Dec 2022
-$25.18 M(-36.4%)
-$5.27 M(-12.9%)
-$25.08 M(-9.9%)
Sep 2022
-
-$6.05 M(-8.3%)
-$27.84 M(-15.8%)
Jun 2022
-
-$6.60 M(-7.8%)
-$33.08 M(-9.7%)
Mar 2022
-
-$7.16 M(-10.8%)
-$36.64 M(-7.4%)
Dec 2021
-$39.59 M(+15.0%)
-$8.03 M(-28.9%)
-$39.59 M(+0.6%)
Sep 2021
-
-$11.29 M(+11.2%)
-$39.37 M(+9.2%)
Jun 2021
-
-$10.16 M(+0.5%)
-$36.04 M(+3.4%)
Mar 2021
-
-$10.11 M(+29.5%)
-$34.86 M(-22.1%)
Dec 2020
-$34.43 M(-13.4%)
-$7.81 M(-2.0%)
-$44.77 M(+471.4%)
Sep 2020
-
-$7.97 M(-11.3%)
-$7.84 M(-62.3%)
Jun 2020
-
-$8.98 M(-55.1%)
-$20.80 M(-50.3%)
Mar 2020
-
-$20.02 M(-168.7%)
-$41.83 M(+6.1%)
Dec 2019
-$39.77 M(-55.3%)
$29.13 M(-239.2%)
-$39.43 M(-56.9%)
Sep 2019
-
-$20.93 M(-30.3%)
-$91.51 M(+0.1%)
Jun 2019
-
-$30.01 M(+70.4%)
-$91.42 M(+10.8%)
Mar 2019
-
-$17.62 M(-23.2%)
-$82.48 M(-7.4%)
Dec 2018
-$89.03 M(+10.5%)
-$22.95 M(+10.1%)
-$89.09 M(-4.4%)
Sep 2018
-
-$20.84 M(-1.1%)
-$93.19 M(+15.2%)
Jun 2018
-
-$21.08 M(-13.0%)
-$80.87 M(-2.0%)
Mar 2018
-
-$24.22 M(-10.5%)
-$82.48 M(+3.0%)
Dec 2017
-$80.60 M(-1.3%)
-$27.05 M(+217.7%)
-$80.05 M(-2.9%)
Sep 2017
-
-$8.52 M(-62.5%)
-$82.47 M(-13.7%)
Jun 2017
-
-$22.69 M(+4.1%)
-$95.55 M(+5.5%)
Mar 2017
-
-$21.79 M(-26.1%)
-$90.56 M(+10.7%)
Dec 2016
-$81.68 M(+106.4%)
-$29.48 M(+36.5%)
-$81.78 M(+30.1%)
Sep 2016
-
-$21.60 M(+22.0%)
-$62.84 M(+25.5%)
Jun 2016
-
-$17.70 M(+36.1%)
-$50.08 M(+17.0%)
Mar 2016
-
-$13.00 M(+23.4%)
-$42.82 M(+8.3%)
Dec 2015
-$39.57 M(+36.1%)
-$10.54 M(+19.2%)
-$39.54 M(+8.0%)
Sep 2015
-
-$8.84 M(-15.3%)
-$36.59 M(+0.6%)
Jun 2015
-
-$10.44 M(+7.4%)
-$36.39 M(+3.6%)
Mar 2015
-
-$9.72 M(+28.0%)
-$35.11 M(+20.7%)
Dec 2014
-$29.09 M(+128.0%)
-$7.59 M(-12.1%)
-$29.09 M(+3.1%)
Sep 2014
-
-$8.64 M(-5.7%)
-$28.22 M(+30.1%)
Jun 2014
-
-$9.16 M(+147.7%)
-$21.69 M(+46.3%)
Mar 2014
-
-$3.70 M(-45.0%)
-$14.82 M(+17.3%)
Dec 2013
-$12.76 M(-841.9%)
-$6.72 M(+219.5%)
-$12.63 M(+184.2%)
Sep 2013
-
-$2.10 M(-8.4%)
-$4.45 M(-993.5%)
Jun 2013
-
-$2.30 M(+52.4%)
$497.50 K(-87.6%)
Mar 2013
-
-$1.51 M(-202.9%)
$4.01 M(+130.8%)
Dec 2012
$1.72 M(-232.4%)
$1.46 M(-48.4%)
$1.74 M(-55.2%)
Sep 2012
-
$2.84 M(+132.9%)
$3.88 M(-1944.2%)
Jun 2012
-
$1.22 M(-132.2%)
-$210.30 K(-93.1%)
Mar 2012
-
-$3.78 M(-205.0%)
-$3.06 M(+107.3%)
Dec 2011
-$1.30 M(-85.4%)
$3.60 M(-388.3%)
-$1.48 M(-83.0%)
Sep 2011
-
-$1.25 M(-23.4%)
-$8.70 M(-14.3%)
Jun 2011
-
-$1.63 M(-25.8%)
-$10.15 M(+12.9%)
Mar 2011
-
-$2.20 M(-39.2%)
-$8.98 M(-4.5%)
Dec 2010
-$8.90 M
-$3.62 M(+34.1%)
-$9.41 M(+25.0%)
Sep 2010
-
-$2.70 M(+474.8%)
-$7.53 M(+45.2%)
DateAnnualQuarterlyTTM
Jun 2010
-
-$469.40 K(-82.1%)
-$5.18 M(-38.8%)
Mar 2010
-
-$2.63 M(+51.3%)
-$8.48 M(+18.6%)
Dec 2009
-$7.23 M(-53.4%)
-$1.74 M(+389.4%)
-$7.15 M(-18.1%)
Sep 2009
-
-$354.60 K(-90.6%)
-$8.72 M(-22.4%)
Jun 2009
-
-$3.76 M(+190.3%)
-$11.24 M(-8.3%)
Mar 2009
-
-$1.30 M(-60.9%)
-$12.25 M(-22.3%)
Dec 2008
-$15.51 M(-18.1%)
-$3.31 M(+15.2%)
-$15.77 M(-15.1%)
Sep 2008
-
-$2.87 M(-39.9%)
-$18.57 M(-14.2%)
Jun 2008
-
-$4.78 M(-0.7%)
-$21.65 M(+5.1%)
Mar 2008
-
-$4.81 M(-21.3%)
-$20.59 M(+7.4%)
Dec 2007
-$18.94 M(-6.1%)
-$6.11 M(+2.7%)
-$19.17 M(+2.0%)
Sep 2007
-
-$5.95 M(+60.1%)
-$18.80 M(-1.4%)
Jun 2007
-
-$3.72 M(+9.8%)
-$19.06 M(-0.6%)
Mar 2007
-
-$3.39 M(-41.0%)
-$19.18 M(-6.9%)
Dec 2006
-$20.18 M(+63.8%)
-$5.74 M(-7.7%)
-$20.59 M(+13.0%)
Sep 2006
-
-$6.22 M(+62.0%)
-$18.22 M(+13.9%)
Jun 2006
-
-$3.84 M(-20.0%)
-$16.00 M(-1.9%)
Mar 2006
-
-$4.80 M(+42.6%)
-$16.31 M(+32.3%)
Dec 2005
-$12.32 M(+13.5%)
-$3.36 M(-15.8%)
-$12.33 M(+5.0%)
Sep 2005
-
-$4.00 M(-3.7%)
-$11.74 M(+7.5%)
Jun 2005
-
-$4.15 M(+411.6%)
-$10.92 M(+39.5%)
Mar 2005
-
-$811.70 K(-70.8%)
-$7.83 M(-28.6%)
Dec 2004
-$10.86 M(-26.3%)
-$2.78 M(-12.7%)
-$10.97 M(-13.8%)
Sep 2004
-
-$3.18 M(+200.4%)
-$12.73 M(-2.5%)
Jun 2004
-
-$1.06 M(-73.2%)
-$13.06 M(-17.8%)
Mar 2004
-
-$3.95 M(-12.9%)
-$15.90 M(+7.4%)
Dec 2003
-$14.73 M(+60.5%)
-$4.54 M(+29.5%)
-$14.81 M(+13.8%)
Sep 2003
-
-$3.51 M(-9.9%)
-$13.01 M(+12.0%)
Jun 2003
-
-$3.89 M(+36.0%)
-$11.62 M(+14.9%)
Mar 2003
-
-$2.86 M(+4.1%)
-$10.11 M(+10.2%)
Dec 2002
-$9.18 M(+67.6%)
-$2.75 M(+30.4%)
-$9.18 M(+12.5%)
Sep 2002
-
-$2.11 M(-11.7%)
-$8.16 M(+12.5%)
Jun 2002
-
-$2.39 M(+23.8%)
-$7.26 M(+15.9%)
Mar 2002
-
-$1.93 M(+11.5%)
-$6.26 M(+14.6%)
Dec 2001
-$5.48 M(+60.5%)
-$1.73 M(+43.7%)
-$5.46 M(+20.7%)
Sep 2001
-
-$1.20 M(-13.7%)
-$4.53 M(+4.7%)
Jun 2001
-
-$1.40 M(+23.3%)
-$4.32 M(+15.7%)
Mar 2001
-
-$1.13 M(+42.8%)
-$3.74 M(+13.5%)
Dec 2000
-$3.41 M(+12.7%)
-$792.70 K(-20.8%)
-$3.29 M(+87.9%)
Sep 2000
-
-$1.00 M(+23.5%)
-$1.75 M(-16.4%)
Jun 2000
-
-$810.60 K(+17.8%)
-$2.10 M(-18.6%)
Mar 2000
-
-$688.00 K(-192.1%)
-$2.58 M(-14.5%)
Dec 1999
-$3.03 M(+66.2%)
$747.30 K(-155.6%)
-$3.01 M(-28.5%)
Sep 1999
-
-$1.35 M(+4.3%)
-$4.21 M(+24.0%)
Jun 1999
-
-$1.29 M(+14.8%)
-$3.40 M(-0.7%)
Mar 1999
-
-$1.12 M(+147.6%)
-$3.42 M(-1.9%)
Dec 1998
-$1.82 M(-49.0%)
-$454.00 K(-14.1%)
-$3.49 M(-19.1%)
Sep 1998
-
-$528.60 K(-59.8%)
-$4.31 M(+14.0%)
Jun 1998
-
-$1.31 M(+10.4%)
-$3.78 M(+53.2%)
Mar 1998
-
-$1.19 M(-6.9%)
-$2.47 M(+93.1%)
Dec 1997
-
-$1.28 M
-$1.28 M
Sep 1997
-$3.58 M
-
-

FAQ

  • What is Liminal BioSciences annual operating income?
  • What is the all time high annual operating profit for Liminal BioSciences?
  • What is Liminal BioSciences annual operating profit year-on-year change?
  • What is Liminal BioSciences quarterly operating income?
  • What is the all time high quarterly operating profit for Liminal BioSciences?
  • What is Liminal BioSciences quarterly operating profit year-on-year change?
  • What is Liminal BioSciences TTM operating income?
  • What is the all time high TTM operating profit for Liminal BioSciences?
  • What is Liminal BioSciences TTM operating profit year-on-year change?

What is Liminal BioSciences annual operating income?

The current annual operating profit of LMNL is -$25.18 M

What is the all time high annual operating profit for Liminal BioSciences?

Liminal BioSciences all-time high annual operating income is $1.72 M

What is Liminal BioSciences annual operating profit year-on-year change?

Over the past year, LMNL annual operating income has changed by +$14.40 M (+36.39%)

What is Liminal BioSciences quarterly operating income?

The current quarterly operating profit of LMNL is -$6.69 M

What is the all time high quarterly operating profit for Liminal BioSciences?

Liminal BioSciences all-time high quarterly operating income is $29.13 M

What is Liminal BioSciences quarterly operating profit year-on-year change?

Over the past year, LMNL quarterly operating income has changed by -$94.20 K (-1.43%)

What is Liminal BioSciences TTM operating income?

The current TTM operating profit of LMNL is -$23.63 M

What is the all time high TTM operating profit for Liminal BioSciences?

Liminal BioSciences all-time high TTM operating income is $4.01 M

What is Liminal BioSciences TTM operating profit year-on-year change?

Over the past year, LMNL TTM operating income has changed by +$9.45 M (+28.58%)